For over 45 years Anthony Nolan has recruited potential stem cell donors to their register – people who are willing to donate their cells to someone in need of a lifesaving stem cell transplant. As this work continues, in parallel we apply our vast experience and dedicated team of experts to help develop new cell-based…
Posts by Jonathan Kay
EBMT Conference 2020 Preview – How Anthony Nolan is improving the services we provide with the help of our patients and healthcare professionals
The European Society for Blood and Marrow Transplantation (EBMT) is an annual event which brings together the world’s leading stem cell transplantation clinicians and scientists to share their latest findings. This year’s conference was due to take place in Madrid but will now be held virtually at the end of August due to the coronavirus…
Is cord blood a better source of stem cells for some blood cancer patients in need of a transplant?
In this blog, our Science Communications Manager, Jonathan Kay, looks at a recent study that highlights the potential benefits of selecting a cord blood transplant over a matched related donor for some patients with blood cancer. Introduction When someone needs a stem cell transplant to treat their blood cancer or blood disorder, they can rely on organisations like…
How research is improving our understanding of COVID-19 and its impact on blood cancer patients
Against daily news articles on COVID-19’s impact and possible new treatments or vaccines, it can be very hard to get a clear picture of the research landscape around the virus. Here Anthony Nolan’s Dr Jonathan Kay summarises the medical research underway to improve our understanding of COVID-19 and examines how it affects patients with blood cancer. Jonathan also talks about IMPACT’s COVID-19 clinical trial for stem cell transplant patients which is part funded by Anthony…
Can certain donor genes protect AML patients from infections after a stem cell transplant?
Anthony Nolan is proud to facilitate three stem cell transplants a day. Though they give patients a vital second chance of life, they can also lead to severe post-transplant complications including relapse, graft vs host disease (GvHD) and infections. But what if we could identify specific genes in the donor which help reduce the risk…
Reducing the risk of infection from cosmetic products and toiletries after your stem cell transplant
In this blog, our Science Communications Manager, Jonathan Kay, looks at how make-up products could cause infections post-transplant and the steps you can take to help reduce the risk. Picking up an infection is an understandable and realistic concern for all stem cell transplant patients because it can take some time for their donor’s stem…